新加坡媒体：在全球制药市场中国扮演重要角色

Core Insights - China plays a crucial role in the global pharmaceutical supply chain, with significant reliance from the US and other countries on Chinese production of pharmaceutical raw materials [1][2] - The US's dependency on China for active pharmaceutical ingredients (APIs) has increased dramatically, with China accounting for 45% of drug master files submitted to the FDA, surpassing India's 19% [1] - A significant portion of active ingredients used in US medications comes from a single source, with China being the exclusive supplier for at least one chemical in nearly 700 critical drugs [2] Group 1 - China has developed a large and commercialized pharmaceutical industry since the 1950s, becoming a key producer of key starting materials (KSMs) used in APIs [1] - The US's reliance on China for pharmaceutical ingredients is underscored by the fact that half of the active ingredients used in the US come from a single source [2] - The trend of dependency on a single supplier raises concerns, especially for a competitive nation like the US, although China has not threatened to halt medical product exports during trade tensions [2] Group 2 - The US government aims to establish a supply chain involving India and other allies to reduce dependency on China, but this is seen as a nearly impossible task due to low profit margins in the production of pharmaceutical raw materials [2] - A US corporate executive noted that replicating the raw material supply chain would increase costs by 50%, indicating the challenges faced by US companies in this endeavor [2] - China's dominance in many critical sectors, including pharmaceuticals, highlights the complexities of global supply chains and the difficulties in achieving "decoupling" from China [2]